肌缩性侧面硬化症与脱髓化神经生理学和机动带信号
Matthew Megens1, Aaron de Souza2,3
1Department of Neurology, Launceston General Hospital, Launceston, Tasmania, Australia.
Practical neurology
|December 5, 2023
概括
这项案例研究突出显示了一种罕见的肌缩性侧面硬化症 (ALS) 呈现,在初步测试中模仿慢性炎症性脱髓化多基原蛋白神经病 (CIDP). 临床和成像发现是确认ALS诊断的关键.
科学领域:
- 神经学 神经学
- 神经生理学 神经生理学
- 神经成像是一种神经成像.
背景情况:
- 肌缩侧面硬化症 (ALS) 是一种进展性神经退行性疾病,影响运动神经元.
- 慢性炎症性脱髓化多基原蛋白神经病 (CIDP) 是一种导致脱髓化的自身免疫性疾病.
- 由于症状重叠,区分ALS和CIDP可能具有挑战性.
研究的目的:
- 报告一个不寻常的ALS病例,最初的神经生理学发现表明CIDP.
- 强调临床表型和神经成像在诊断异型ALS病例中的重要性.
- 讨论ALS和脱髓化变化之间的罕见关联.
主要方法:
- 一个68岁的男性的病例报告,肢体逐渐变弱.
- 神经生理学研究包括神经传导研究.
- 大脑脊髓液分析.
- 大脑的磁共振成像 (MRI).
主要成果:
- 最初的神经生理学研究显示了感觉运动脱髓化变化,模仿CIDP.
- 脑脊髓液分析支持了脱髓神经病变的诊断.
- 大脑MRI扫描显示了一个"机动带",这是ALS的特征.
- 患者对免疫疗法的耐药反应和临床进展证实了ALS.
结论:
- 罕见地,ALS会出现类似于CIDP的神经生理学和初始诊断发现.
- 在这种情况下,临床表现和神经成像对于准确的ALS诊断至关重要.
- 这一案例强调了诊断方面的挑战,以及整合多种诊断模式的重要性.
相关概念视频
Cross-bridge Cycle
117.5K
As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
117.5K
Myasthenia Gravis: Diagnostic Tests
890
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
890
Neural Regulation
39.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.5K
Parkinson's Disease: Overview
557
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
557
Disorders of the Skeletal Muscle
966
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
966
Chemical Synapses
8.8K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
8.8K


